LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH
LIVE

Serial Number

79215315

Owner

LIMMATECH BIOLOGICS AG

Attorney

Christina L. Martini, Esq.

Filing Date

Apr 7, 2017

Add to watchlist:

No watchlists yet
View on USPTO

LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH Trademark

Serial Number: 79215315 • Registration: 5619534

LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH is a trademark filed by LIMMATECH BIOLOGICS AG on April 7, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

LIMMATECH BIOLOGICS AG

Grabenstrasse 3

Entity Type: 03

Trademark Details

Filing Date

April 7, 2017

Registration Date

December 4, 2018

Published for Opposition

September 18, 2018

Cancellation Date

June 20, 2025

Goods & Services

Training courses related to research and development of pharmaceuticals; organizing conferences in the field of education for non-business and/or non-commercial purposes; arranging and conducting educational conferences in the field of pharmaceuticals; arranging of seminars; organizing educational conferences in the field of teaching; organization of in-person educational, forum in the field of pharmaceuticals; organization of educational seminars, and organizing conferences in the field of education; organizing conferences in the field of pharmaceuticals and conducting of educational conferences for non-business and/or non-commercial purposes; organizing educational conferences and symposiums in the field of medical science; editing of written text in the nature of medical publications; publication of printed materials and printed publications, namely, magazines; newspapers, leaflets; publication of texts; all the aforesaid services from Switzerland

Packaging, namely, blister packs; packages, namely, boxes of cardboard and paper; promotional material in the nature of advertising posters, instructional sheets in the field of pharmaceuticals, and information material in the nature of pharmaceutical information leaflets; paper, cardboard, printed teaching materials in the field of pharmaceuticals; printed products, namely, leaflets for pharmaceutical products, pamphlets in the field of pharmaceuticals, manuals in the field of pharmaceuticals, leaflets about pharmaceutical preparations for the treatment of disorders to be treated by means of therapeutics and vaccines, posters, prospectuses featuring information concerning company business in the nature of pharmaceutical products, newsletters about company business in the nature of pharmaceutical products, document files; photographs; graphic representations; business cards; all the aforesaid goods are of Swiss origin

Pharmaceutical products for the treatment of any disease or conditions to be treated by means of therapeutics and vaccines, namely, cancer, autoimmune, inflammatory, bacterial and viral diseases; all the aforesaid goods of Swiss origin

Scientific research services; medical research; biological research services; clinical research in the field of pharmaceuticals; scientific research and providing information in the fields of biochemistry and biotechnology; genetic research; biological research, clinical research in the field of therapeutics and vaccines, and medical research; product research; laboratory research in the field of pharmaceuticals; technical research in the field of pharmaceutical studies; scientific research; scientific research and development; providing laboratory research services in the field of therapeutics and vaccines; scientific research in the field of biology; information relating to scientific research, namely, scientific research information in the field of pharmaceutical; research in the field of molecular science; scientific research in the field of genetics; product research and development in the field of biotechnology; laboratory research services in the field of dermatology; scientific research in the field of genetics and genetic engineering; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; all the aforesaid services from Switzerland

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 20, 2026 INTR
CANCELLED SECTION 71
Jun 20, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 4, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 10, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 19, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 19, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 4, 2019 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 4, 2019 NREP
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 18, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Sep 15, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 29, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 29, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 29, 2018 NONP
ASSIGNED TO LIE
Aug 10, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 25, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 25, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 25, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 25, 2018 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 23, 2018 GNFN
FINAL REFUSAL E-MAILED
Apr 23, 2018 GNFR
FINAL REFUSAL WRITTEN
Apr 23, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2018 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2018 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2018 REAP
REFUSAL PROCESSED BY IB
Oct 7, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 18, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 18, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2017 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 9, 2017 MAFR
ASSIGNED TO EXAMINER
Sep 5, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 31, 2017 REPR